Despite the growing number of reports tying the use of ephedra to illnesses and deaths, the federal government has yet to ban the herbal supplement. A powerful congressional lobby has helped protect ephedra manufacturers from efforts to ban or more strictly regulate its use. NPR's Snigdha Prakash reports.
A panel of experts takes on the question in the latest Intelligence Squared U.S. debate.
Commentator Andrew Wallenstein says the rocker's marketing deal shows the old rules no longer hold.
If Wall Street wants to win back public respect, it needs to act in the public's interests.
Meet high rollers, brainy economists and regular folks -- all trying to make sense of our rapidly changing global economy.
The top business story of the day from Morning Edition, All Things Considered and other award-winning NPR programs.
Comments
Discussions for this story are now closed. Please see the Community FAQ for more information.